BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today announced its operating and financial results for the quarter ended September 30, 2025. “During the quarter, we received constructive regulatory guidance from the FDA on our pre-IND submission for GB3226, a novel small molecule dual inhibitor of ENL-YEATS and FLT3 with potential to address a broad portion of patie ...

Two Presentations at ASH 2025 to highlight preclinical data and clinical development plans for GB3226, a novel dual ENL-YEATS and FLT3 inhibitor for the treatment of acute myeloid leukemia (AML) BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today announced that preclinical data and clinical development plans for its investigational candidate GB3226 will be featured ...

市场整体表现 - 市场分析关注股价出现显著波动的几大跌幅居前公司 包括Cenntro Electric Group Limited (CENN) Galecto Inc (GLTO) 和 Zeta Network Group (ZNB) [1] - 股价波动反映了多种因素 包括市场情绪 行业特定挑战以及更广泛的经济状况 [1] Cenntro Electric Group Limited (CENN) - 公司股价下跌41.71%至0.36美元 [2] - 公司正扩大其在电动汽车市场的业务 与Electricove Maroc建立战略合作伙伴关系 在摩洛哥设立电动汽车组装业务 [2] Galecto Inc (GLTO) - 公司股价下跌39.84%至10.78美元 [3] - 交易量激增 达到6111万股 远高于其984320股的平均水平 表明投资者对其针对纤维化 癌症和炎症的创新疗法兴趣高涨 [3] Zeta Network Group (ZNB) - 公司股价下跌44.71%至1.87美元 [4] - 公司从Color Star Technology Co Ltd 更名为Zeta Network Group 代表了战略重点的转变 [4]

美股市场表现 - 纳斯达克综合指数上涨超过150点，涨幅0.70%，报22,947.47点 [1] - 道琼斯工业平均指数上涨0.08%，报46,642.55点 [1] - 标普500指数上涨0.35%，报6,738.32点 [1] - 信息技术板块领涨，涨幅达1.1% [1] - 能源板块表现落后，下跌0.9% [1] 商品市场动态 - 原油价格上涨0.9%，至每桶62.26美元 [4] - 黄金价格上涨1.3%，至每盎司4,058.00美元 [4] - 白银价格上涨1.9%，至每盎司48.395美元 [4] - 铜价上涨0.1%，至每磅5.0985美元 [4] 全球股市概况 - 欧洲斯托克600指数上涨0.7% [5] - 西班牙IBEX 35指数上涨0.8% [5] - 英国富时100指数上涨0.6% [5] - 德国DAX指数上涨0.8% [5] - 法国CAC 40指数上涨0.9% [5] - 日本日经225指数下跌0.45% [6] - 香港恒生指数下跌0.48% [6] - 印度孟买Sensex指数下跌0.19% [6] 个股异动情况 - Xenetic Biosciences股价飙升174%，至11.75美元 [8] - Connexa Sports Technologies股价大涨102%，至0.3639美元 [8] - AlphaTON Capital股价上涨81%，至10.08美元 [8] - Galecto股价下跌42%，至10.48美元，此前一个交易日曾暴涨383% [8] - Zeta Network Group股价下跌41%，至2.00美元，公司宣布以每股1.00美元的价格定向增发1500万股 [8] - Envoy Medical股价下跌38%，至0.9854美元，公司宣布进行400万美元的定向增发和私募配售 [8] 经济数据 - 美国抵押贷款申请量在截至10月3日的一周内下降4.7%，而前一周为大幅下降12.7% [2][7]

美股市场整体表现 - 周二美国主要股指收跌，道琼斯工业平均指数下跌0.2%至46,602.98点，标准普尔500指数下跌近0.4%至6,714.59点，纳斯达克综合指数下跌约0.7%至22,788.36点 [1] POET Technologies Inc (POET) - POET Technologies股价大幅上涨23.51%，收于7.88美元，盘中最高触及8.13美元，52周区间为3.10美元至8.13美元 [2] - 公司宣布完成一项非经纪私募配售，向单一机构投资者筹集7500万美元，通过发行1360万股股票及附带认股权证实现，此为该公司历史上最大规模投资 [3] - 募集资金计划用于公司发展、研发扩张以及扩展其人工智能相关光源业务 [3] Oracle Corp (ORCL) - Oracle股价下跌2.52%，收于284.24美元，盘中交易区间为271美元至293.22美元，52周区间为118.86美元至345.72美元 [4] - 股价下跌与报告称其租赁英伟达芯片面临财务挑战相关，上季度因此造成近1亿美元损失，过去一年此类租赁业务的平均毛利率约为16% [4] NUBURU Inc (BURU) - Nuburu股价飙升86.27%，收于0.48美元，盘后交易中进一步上涨24.5%至0.59美元，52周区间为0.12美元至1.60美元 [5] - 股价上涨源于公司宣布其国防子公司收购了意大利软件公司Orbit S.r.l.，此举标志着公司向国防软件领域的战略扩张，以增强其任务保证能力 [5] Galecto Inc (GLTO) - Galecto股价暴涨383.02%，收于17.92美元，盘中最高达31.70美元，52周区间为2.01美元至31.70美元，但盘后交易中下跌25.6%至13.33美元 [6] - 尽管公司未有新闻发布，但股价因投机活动大幅上涨，成交量超过平均水平的60倍，该生物技术公司截至2025年6月现金头寸为1020万美元，预计运营资金可支撑至2026年，但其癌症和肝脏疾病项目（包括GB3226和GB1211）仍需额外资金 [7] TMC The Metals Company (TMC) - TMC The Metals Company股价上涨20.21%，收于9.28美元，盘中最高为9.55美元，52周区间为0.72美元至9.55美元 [8] - 股价上涨受到特朗普政府对金属行业投资的推动，引发了市场对稀土和电池金属的兴趣 [8]

Galecto公司股价表现 - Galecto公司股价飙升至2269美元，涨幅达51159% [1] - 交易量超过7000万股，远高于其平均不足100万股的交易量 [1] - 股价异动归因于其主打候选产品GB2064和GB0139的积极进展 [1] Trilogy Metals公司股价表现 - Trilogy Metals公司股价跃升至706美元，涨幅达2378% [2] - 交易量近180亿股 [2] - 股价上涨反映投资者对基础金属行业潜力的乐观情绪，特别是关键矿物需求上升 [2] Envoy Medical公司股价表现 - Envoy Medical公司COCH股价上涨8853%至152美元，交易量超过137亿股 [3] - COCHW股价上涨21225%至010美元，交易量约843,111股 [3] - 公司获得FDA批准，将其Acclaim®人工耳蜗植入物关键临床试验推进至最后阶段 [3] Zeta Network Group公司股价表现 - Zeta Network Group公司股价攀升至313美元，涨幅达8855% [4] - 交易量超过140亿股 [4] - 公司通过在线娱乐表演和音乐教育服务的创新方法吸引了投资者 [4] 市场整体动态 - 市场呈现动态环境，投资者对公司发展、技术进步和市场趋势做出积极反应 [5] - 显著的价格变化和交易量凸显了市场波动性及其带来的机会 [5]

Galecto (GLTO), a small-cap biotechnology company, saw its shares soar as much as 750% on Tuesday as retail investors flocked into them for no apparent reason. The massive surge in trading volume resembles a meme stock rally given GLTO didn’t post a new press release or regulatory filing, neither did it receive bullish analyst coverage today. More News from Barchart While GLTO stock has pulled back rather significantly in recent hours, at one point on Oct. 7, it was seen trading 1,500% above its year-to ...

Galecto Inc. (NASDAQ:GLTO) stock spiked on Tuesday, with a session volume of 61.11 million, compared to the average volume of 984,320, as per data from Benzinga Pro.However, there is no news to justify this extraordinary rally, suggesting speculative trading.As of June 30, 2025, cash and cash equivalents were approximately $10.2 million.The company anticipates that its cash and cash equivalents will be sufficient to fund operating expenses and capital requirements through 2026, including the submission of a ...

Galecto stock (NASDAQ: GLTO) went absolutely bonkers on Tuesday, surging over 600% in what might be one of the wildest rallies we have seen from a small biotech in recent memory. The shares jumped fro... ...

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Tuesday.Following the market opening Tuesday, the Dow traded up 0.33% to 46,847.49 while the NASDAQ rose 0.11% to 22,967.90. The S&P 500 also rose, gaining, 0.15% to 6,750.64.Check This Out: Cramer Warns On One Chip Stock, Says Broadcom Is The Better BetLeading and Lagging SectorsFinancials shares jumped by 0.6% on Tuesday.In trading on Tuesday, consumer discretionary stocks fell by 0.4%.Top HeadlineMcCormick & ...